AMO 5G femtosecond laser cleared by FDA

Article

The FDA has cleared the iFS Advanced Femtosecond Laser (AMO), which is now available for order.

The FDA has cleared the iFS Advanced Femtosecond Laser (AMO), which is now available for order.

The fifth generation laser, which can cut a corneal flap within 10 seconds, includes IntraLase-Enabled Keratoplasty (IEK), and has a higher repetition rate and tighter spot separation than earlier models. It has a unique inverted bevel-in-side cut angle to improve the biomechanical stability of postoperative corneas, and can create an elliptical flap to increase the number of surgical options.

The iFS laser - part of AMO's proprietary iLASIK technology suite - has an ergonomic design, new contemporary user interface and high-resolution digital video microscope, all designed to increase surgeon comfort and ease of operating, enhancing the outcome for the patient.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.